Singapore HSA Approves HIV-1 Infection Treatment for Adults
In clinical trials, biktarvy demonstrated high efficacy and zero resistance through 48 weeks. The Singapore Health Sciences Authority has approved Gilead Sciences’ Biktarvy, a once-daily single...